Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Dyspepsia | D004415 | EFO_0008533 | K30 | 1 | — | — | — | — | 1 |
Gastritis | D005756 | EFO_0000217 | K29.7 | 1 | — | — | — | — | 1 |
Drug common name | Mosapride |
INN | mosapride |
Description | Mosapride is a racemate comprising equimolar amounts of (R)- and (S)-mosapride. It is a gastroprokinetic agent which acts on 5-hydroxytryptamine type 4 (5-HT4) receptors in the gastrointestinal plexus, consequently increasing the release of acetylcholine and hence enhancing gastrointestinal motility and gastric emptying. It has a role as a gastrointestinal drug and a serotonergic agonist. It contains a (R)-mosapride and a (S)-mosapride. |
Classification | Small molecule |
Drug class | sulpride derivatives and analogs |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1 |
PDB | — |
CAS-ID | 112885-41-3 |
RxCUI | — |
ChEMBL ID | CHEMBL60889 |
ChEBI ID | — |
PubChem CID | 119584 |
DrugBank | DB11675 |
UNII ID | I8MFJ1C0BY (ChemIDplus, GSRS) |